The pharmacologist

Ana Belén Elgoyhen; Carla Vanina Rothlin

doi:10.1007/978-1-60761-145-5_30

The pharmacologist

Ana Belén Elgoyhen, Carla Vanina Rothlin

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus.

Original language	English (US)
Title of host publication	Textbook of Tinnitus
Publisher	Springer New York
Pages	251-257
Number of pages	7
ISBN (Print)	9781607611448
DOIs	https://doi.org/10.1007/978-1-60761-145-5_30
State	Published - 2011
Externally published	Yes

Keywords

Animal models
Drug discovery
Lead compounds
Phantom sound
Tinnitus

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-60761-145-5_30

Cite this

@inbook{6cad87d2037f4cf3b806eec1f9635ffa,

title = "The pharmacologist",

abstract = "Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus.",

keywords = "Animal models, Drug discovery, Lead compounds, Phantom sound, Tinnitus",

author = "Elgoyhen, {Ana Bel{\'e}n} and Rothlin, {Carla Vanina}",

year = "2011",

doi = "10.1007/978-1-60761-145-5_30",

language = "English (US)",

isbn = "9781607611448",

pages = "251--257",

booktitle = "Textbook of Tinnitus",

publisher = "Springer New York",

}

TY - CHAP

T1 - The pharmacologist

AU - Elgoyhen, Ana Belén

AU - Rothlin, Carla Vanina

PY - 2011

Y1 - 2011

N2 - Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus.

AB - Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus.

KW - Animal models

KW - Drug discovery

KW - Lead compounds

KW - Phantom sound

KW - Tinnitus

UR - http://www.scopus.com/inward/record.url?scp=84887945170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887945170&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-145-5_30

DO - 10.1007/978-1-60761-145-5_30

M3 - Chapter

AN - SCOPUS:84887945170

SN - 9781607611448

SP - 251

EP - 257

BT - Textbook of Tinnitus

PB - Springer New York

ER -

The pharmacologist

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this